Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment. Pediatric Blood and Cancer. 2023; 70:e30219.
.NRASQ61R mutation in human endothelial cells causes vascular malformations. Angiogenesis. 2022; 25:331-342.
.Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19). Angiogenesis. 2021; 24:403-406.
.Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin-2 levels. Pediatric Blood and Cancer. 2020; 67:e28529.
.Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation. Angiogenesis. 2020; 23:425-442.
.Comment on: Potential biomarkers of kaposiform lymphangiomatosis. Pediatric Blood and Cancer. 2020; 67:e28100.
.Early Disruption of VEGF Receptor Signaling and the Risk for Adult Emphysema. American Journal of Respiratory and Critical Care Medicine. 2020; 201:620-621.
.Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis. Pediatric Blood and Cancer. 2019; 66:e27790.
.Cellular and molecular mechanisms of PIK3CA-related vascular anomalies. Vascular Biology. 2019; 1:H33-H40.
.Ponatinib Combined With Rapamycin Causes Regression of Murine Venous Malformation. Arteriosclerosis, Thrombosis, and Vascular Biology. 2019; 39:496-512.
.